Cell Therapy Company Raises $65M In Funding Round
A company that specializes in transplanting cells to treat cancers and infectious diseases announced Monday that it raised $65 million in a funding round led by Singapore's state-owned investment company....To view the full article, register now.
Already a subscriber? Click here to view full article